ArticleExpert opinion on investigational drugs2012
Dalcetrapib--restoring belief in modulating CETP as a beneficial mechanism in cardiovascular disease.
Sheila A DoggrellPubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it